USPTO serial 79397877
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Emily M. Haas
Emily M. Haas Michael Best & Friedrich LLP4509 Creedmoor RoadSuite 501Raleigh, NC 27612| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Commercial consulting concerning the development and marketing of cosmetic products, pharmaceuticals, nutraceuticals, medicines, food supplements, medical apparatus and devices; market research studies; advice on undertaking communication namely advice on the implementation of advertising communication strategies related to cosmetic products, pharmaceuticals, nutraceuticals, medicines, food supplements, medical apparatus and devices; setting up communication tools namely providing public relations in the context of the commercial introduction of cosmetic products, pharmaceutical, nutraceutical, medicine, food supplements, medical apparatus and devices; commercial advice relating to the export of cosmetic products, pharmaceuticals, nutraceuticals, medicines, food supplements, medical apparatus and devices | ACTIVE | — |
| 042 | Providing scientific research and technology research services in the field of pharmaceutical, nutraceutical, cosmetic products, medicine, food supplements, medical apparatus and devices; drafting expert reports in the nature of technical project studies in the nature of conducting scientific and technological feasibility studies in the field of development of pharmaceutical, nutraceutical, cosmetic products, medicine, food supplements, medical apparatus and devices; technical and scientific assistance in drafting of user instructions, namely, technical writing for others for pharmaceutical, nutraceutical, cosmetic products, medicine, food supplements, medical apparatus and devices; providing scientific research information in the nature of data and results from pharmaceutical, clinical, biological and medical research and development from an online searchable database; scientific, pharmaceutical, clinical, biological and medical research services conducted using databases; design, installation, development, updating and maintenance services for computer software for the provision of information, results and data relating to scientific, pharmaceutical, clinical, biological and medical research and development; Software-as-a-Service (SAAS) services in the nature of hosting cloud-based software for others for the provision of information, results, and data relating to scientific, pharmaceutical, clinical, biological, and medical research and development; database design and development for the provision of information, results, and data relating to scientific, pharmaceutical, clinical, biological, and medical research and development; development, updating, and maintenance of database systems for the provision of information, results, and data relating to scientific, pharmaceutical, clinical, biological, and medical research and development; computer services, namely providing electronic storage of data with respect to scientific, pharmaceutical, clinical, biological and medical research and development; providing temporary use of online non-downloadable computer software for collecting and analyzing data in the fields of scientific, pharmaceutical, clinical, biological and medical research and development; providing Internet search engines in the field of scientific, pharmaceutical, clinical, biological and medical data and information; computer software consultation for computer database programs and systems relating to the provision of information, results and data with respect to scientific, pharmaceutical, clinical, biological and medical research and development | ACTIVE | — |
| 045 | Regulatory advice, namely, reviewing standards and practice to assure compliance with laws and regulations and legal advice in the field of development, implementation and marketing of pharmaceutical, nutraceutical, cosmetic products, medicine, food supplements, medical apparatus and devices; regulatory advice, namely, reviewing standards and practice to assure compliance with laws and regulations and legal advice for the purpose of drawing up user instructions for pharmaceutical, nutraceutical, cosmetic products, medicine, food supplements, medical apparatus and devices; information and advice for obtaining legal authorizations, namely, marketing authorization in the nature of securing regulatory approval licensing of intellectual property for marketing of pharmaceutical, nutraceutical, cosmetic products, medicine, food supplements, medical apparatus and devices | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 5, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 14, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 14, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 5, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 19, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 19, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 5, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 5, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 5, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 17, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 17, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 11, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 13, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 8, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 24, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 24, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 24, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 24, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 31, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 31, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 31, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 26, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 7, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 7, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 2, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 1, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 24, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 21, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 21, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 20, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |